<code id='845D46C371'></code><style id='845D46C371'></style>

<acronym id='845D46C371'></acronym>

<center id='845D46C371'><center id='845D46C371'><tfoot id='845D46C371'></tfoot></center><abbr id='845D46C371'><dir id='845D46C371'><tfoot id='845D46C371'></tfoot><noframes id='845D46C371'>

<optgroup id='845D46C371'><strike id='845D46C371'><sup id='845D46C371'></sup></strike><code id='845D46C371'></code></optgroup>

<b id='845D46C371'><label id='845D46C371'><select id='845D46C371'><dt id='845D46C371'><span id='845D46C371'></span></dt></select></label></b><u id='845D46C371'></u>

~~<i id='845D46C371'><strike id='845D46C371'><tt id='845D46C371'><pre id='845D46C371'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

leisure time

author：explore 2025-10-04 11:32:19 Page View：4

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： SAMSHA loosens regulations on methadone treatment centers
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

leisure time

In Memoriam: Notable people who died in 2023

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

A new study asks: Are we harming blood donors by taking blood?

A new study asks: Are we harming blood donors by taking blood?

AphlebotomistcollectvialsofbloodatadonationcenterinSanFrancisco.JustinSullivan/GettyImagesOnequestio

Alkermes shareholders re

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Vertex non

JOSEPHPREZIOSO/AFPviaGettyImagesLate-stagetrialresultsforapainmedicationdevelopedbyVertexPharmaceuti

read more